Shenzhen Chipscreen Biosciences Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 183.307 million compared to CNY 110.589 million a year ago. Operating loss was CNY 8.115 million compared to operating Income of CNY 30.985 million a year ago. Net loss was CNY 7.152 million compared to net income of CNY 28.711 million a year ago. Basic loss per share from continuing operations was CNY 0.0174 compared to basic earnings per share from continuing operations of CNY 0.07 a year ago.